Diagnosis and treatment of subclinical hypercortisolism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 5, 2011, Pages 1223-1236

  Chiodini, Iacopo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADRENAL DISEASE; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCRINE SURGERY; HORMONE DETERMINATION; HUMAN; HYPERCORTISOLISM; HYPERTENSION; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; ADRENAL TUMOR; ADULT; CHILD; CUSHING SYNDROME; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADRENAL GLAND NEOPLASMS; ADULT; CHILD; CUSHING SYNDROME; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; TREATMENT OUTCOME;

EID: 79955668917     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2722     Document Type: Review

References (109)

1. Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G, Angeli A 2005 Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinol Metab Clin North Am 34:423-439, x
2. Reincke M 2000 Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:47-56
3. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal masses (" incidentaloma"). Ann Intern Med 138: 424-429
4. Nawar R, Aron D 2005 Adrenal incidentalomas - a continuing management dilemma. Endocr Relat Cancer 12:585-598
5. Terzolo M, Reimondo G, Bovio S, Angeli A 2004 Subclinical Cushing's syndrome. Pituitary 7:217-223
6. Griffing GT 1994 Editorial A-I-D-S: the new endocrine epidemic. J Clin Endocrinol Metab 79:1530-1531
7. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL 1982 Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol 139:81-85
8. Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M 2006 Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29:298-302
9. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85:637-644
10. Chidiac RM, Aron DC 1997 Incidentaloma. A disease of modern technology. Endocrinol Metab Clin North Am 26:233-253
11. Young Jr WF 2000 Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159-185, x
12. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M 1999 Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520-526
13. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149:273-285
14. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540
15. Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998-1003
16. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E 2001 Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86:5301-5306
17. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G 2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87:4872-4878
18. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448
19. Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, CammisaM,Trischitta V, Scillitani A 2004 Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effect of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab 89:2237-2241
20. Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F, Muscarella S, Ambrosi B, Arosio M, Beck-Peccoz P, Scillitani A 2009 Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clin Endocrinol (Oxf) 70:208-213
21. Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A 2009 Bone mineral density, prevalence of vertebral fractures and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian Multicenter Study. J Clin Endocrinol Metab 94:3207-3214
22. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall'Asta C, Bemporad D, Angeli A, Opocher G, Mannelli M, Ambrosi B, Mantero F 2005 Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol 153:307-315
23. Tsagarakis S, Vassiliadi D, Thalassinos N 2006 Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 29:471-482
24. Valassi E, Swearingen B, Lee H, Nachtigall LB, Donoho DA, Klibanski A, Biller BM 2009 Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J Clin Endocrinol Metab 94:4851-4859
25. van Rossum EF, Russcher H, Lamberts SW 2005 Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene. Trends Endocrinol Metab 16: 445-450
26. Manenschijn L, van den Akker EL, Lamberts SW, van Rossum EF 2009 Clinical features associated with glucocorticoid receptor polymorphisms: an overview. Ann NY Acad Sci 1179:179-198
27. Szappanos A, Patócs A, Tõke J, Boyle B, Sereg M, Majnik J, Borgulya G, Varga I, Likó I,RáczK, Tóth M 2009 BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxf) 71:636-643
28. Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P, Chiodini I 2010 Role of glucocorticoid receptor polymorphisms in adrenal incidentalomas. Eur J Clin Invest 40:803-811
29. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocr Rev 25:831-866
30. Hwang JY, Lee SH, Kim GS, Koh JM, Go MJ, Kim YJ, Kim HC, Kim TH, Hong JM, Park EK, Lee JY, Kim SY 2009 HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without clinically apparent hypercortisolemia. Bone 45:1098-1103
31. Nunes ML, Vattaut S, Corcuff JB, Rault A, Loiseau H, Gatta B, Valli N, Letenneur L, Tabarin A 2009 Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94: 456-462
32. Masserini B, Morelli V, Bergamaschi S, Ermetici F, Eller-Vainicher C, Barbieri AM, Maffini MA, Scillitani A, Ambrosi B, Beck-Peccoz P, Chiodini I 2009 The limited role of midnight salivary cortisol in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas. Eur J Endocrinol 160:87-92
33. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM 1991 Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110:1014-1021
34. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W 1992 Preclinical Cushing's syndrome in adrenal incidentalomas: comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75:826-832
35. Osella G, Terzolo M, Borretta G, Magro G, Alí A, Piovesan A, Paccotti P, Angeli A 1994 Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 79:1532-1539
36. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M 1995 Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf) 42:129-134
37. Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P, Sartorio A, Faglia G 1995 Abnormalities of endocrine function in patients with clinically silent adrenal masses. Eur J Endocrinol 132: 422-428
38. Bardet S, Rohmer V, Murat A, Guillemot C, Maréchaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B 1996 131I-6-b-Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 44: 587-596
39. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P, Valentini A, Pansini R, degli Uberti EC 1997 Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 46:107-113
40. Kasperlik-Zeluska AA, Rosłonowska E, Słowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H 1997 Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 46:29-37
41. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N 1998 Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 49:165-171
42. Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A 1998 Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48:89-97
43. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V, Scillitani A 1999 Altered bone mass and turnover in female patients with adrenal incidentalomas: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 84:2381-2385
44. Tanabe A, Naruse M, Nishikawa T, Yoshimoto T, Shimizu T, Seki T, Takagi S, Imaki T, Takano K 2001 Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 33:444-450
45. Favia G, Lumachi F, Basso S, D'Amico DF 2000 Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 128:918-924
46. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T 2001 The improvement of insulin resistance in patients with adrenal incidentalomas by surgical resection. Clin Endocrinol (Oxf) 54:797-804
47. Grossrubatscher E, Vignati F, Possa M, Lohi P 2001 The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. J Endocrinol Invest 24:846-855
48. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F, Tabarin A 2001 Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144:401-408
49. Chiodini I, Torlontano M,Carnevale V, Guglielmi G, Cammisa M, Trischitta V, Scillitani A 2001 Bone loss rate in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab 86:5337-5341
50. Barzon L, Fallo F, Sonino N, Boscaro M 2002 Development of overt Cushing's syndrome in patients with adrenal incidentalomas. Eur J Endocrinol 146:61-66
51. Bülow B, Ahrén B 2002 Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-246
52. Libegrave; R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494
53. Chiodini I, Tauchmanovà L, Torlontano M, Battista C, Guglielmi G, Cammisa M, Colao A, Carnevale V, Rossi R, Di Lembo S, Trischitta V, Scillitani A 2002 Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism. J Clin Endocrinol Metab 87:5491-5494
54. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V, Erdogan G 2003 Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentalomas: clinical, biochemical and surgical outcomes. Endocr J 50:399-408
55. Hadjidakis D, Tsagarakis S, Roboti C, Sfakianakis M, Iconomidou V, Raptis SA, Thalassinos N 2003 Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin Endocrinol (Oxf) 58:72-77
56. Katabami T, Obi R, Shirai N, Naito S, Saito N 2005 Discrepancies in results of low- and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome. Endocr J 52:463-469
57. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E 2009 Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg 249:388-391
58. Eller-Vainicher C, Morelli V, Salcuni AS, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Carnevale V, Beck- Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I 2010 Postsurgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol 162:91-99
59. Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Savoca C, Viti R, Coletti F, Guglielmi G, Battista C, Iorio L, Beck-Peccoz P, Ambrosi B, Arosio M, Scillitani A, Chiodini I 2010 Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin Endocrinol (Oxf) 73:161-166
60. Eller-Vainicher C, Morelli V, Salcuni AS, Battista C, Torlontano M, Coletti F, Iorio L, Cairoli E, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I 2010 Accuracy of several parameters of hypothalamic-pituitary- adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. Eur J Endocrinol 163:925-935
61. Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V, Scillitani A 2010 Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab 95: 2736-2745
62. Stewart PM 2010 Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. J Clin Endocrinol Metab 95:2618-2620
63. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ 1996 Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44:717-722
64. 2002 NIH State-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). 2002 NIH Consensus and State-of-the-Science Statements 19:1-23
65. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J 2009 American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1-20
66. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602 (Pubitemid 38033020)
67. Barzon L, Fallo F, Sonino N, Boscaro M 2001 Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. Eur J Endocrinol 145:223-224 (Pubitemid 32707610)
68. Tabarin A, Bardet S, Bertherat J, Dupas B, Chabre O, Hamoir E, Laurent F, Tenenbaum F, CazaldaM,Lefebvre H, Valli N, Rohmer V 2008 Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Ann Endocrinol (Paris) 69:487-500
69. Kidambi S, Raff H, Findling JW 2007 Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol 157:725-731
70. Duclos M,Corcuff JB, Etcheverry N, Rashedi M,Tabarin A, Roger P 1999 Abdominal obesity increases overnight cortisol excretion. J Endocrinol Invest 22:465-471 (Pubitemid 29355564)
71. Taylor RL, Machacek D, Singh RJ 2002 Validation of a high throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 48:1511-1519 (Pubitemid 34925786)
72. Boscaro M, Barzon L, Sonino N 2000 The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med 160:3045-3053
73. Newell-Price J, Trainer P, Besser M, Grossman A 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo- Cushing's states. Endocr Rev 19:647-672 (Pubitemid 28467716)
74. Mazzuco TL, Bourdeau I, Lacroix A 2009 Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 16:203-210
75. Sereg M, Toke J, Patócs A, Varga I, Igaz P, Szücs N, Horányi J, Pusztai P, Czirják S, Gláz E, Rácz K, Tóth M 2011 Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids 76:38-42
76. Raff H, Findling JW 2003 A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980-991 (Pubitemid 38129119)
77. Bencsik Z, Szabolcs I, Kovács Z, Ferencz A, Vörös A, Kaszás I, Bor K, Gönczi J, Góth M, Kovács L, Dohán O, Szilágyi G 1996 Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. J Clin Endocrinol Metab 81:1726-1729 (Pubitemid 26152453)
78. Rizza RA, Wahner HW, Spelsberg TC, Northcutt RC, Moses HL 1978 Visualization of nonfunctioning adrenal adenomas with iodocholesterol: possible relationship to subcellular distribution of tracer. J Nucl Med 19:458-463 (Pubitemid 8327535)
79. Donadio F, Morelli V, Salcuni AS, Eller-Vainicher C, Carletto M, Castellani M, Dellavedova L, Scillitani A, Beck-Peccoz P, Chiodini I 2009 Role of adrenal gland scintigraphy in patients with incidentally discovered adrenal mass and subclinical hypercortisolism. J Endocrinol Invest 32:576-580
80. Fagour C, Bardet S, Rohmer V, Arimone Y, Lecomte P, Valli N, Tabarin A 2009 Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multi center study. Eur J Endocrinol 160:257-264
81. Contreras LN, Cardoso E, Lozano MP, Pozzo J, Pagano P, Claus- Hermbeg H 2000 Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients. Medicina (B Aires) 60:326-330
82. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A 2003 Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88:5808-5813 (Pubitemid 38033055)
83. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V 2005 Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 153:837-844
84. Taniguchi T, Hamasaki A, Okamoto M 2008 Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus. Endocr J 55:429-432 (Pubitemid 351670972)
85. Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M 2007 Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67:225-229 (Pubitemid 47076296)
86. Newsome S, Chen K, Hoang J, Wilson JD, Potter JM, Hickman PE 2008 Cushing's syndrome in a clinic population with diabetes. Intern Med J 38:178-182 (Pubitemid 351271400)
87. Mullan K, Black N, Thiraviaraj A, Bell PM, Burgess C, Hunter SJ, McCance DR, Leslie H, Sheridan B, Atkinson AB 2010 Is there a value in routine screening for Cushing's syndrome in patients with diabetes? J Clin Endocrinol Metab 95:2262-2265
88. Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E 2005 Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxf) 63:642-649 (Pubitemid 41779637)
89. Khanine V, Fournier JJ, Requeda E, Luton JP, Simon F, Crouzet J 2000 Osteoporotic fractures at presentation of Cushing's disease: two case reports and a literature review. Joint Bone Spine 67:341-345 (Pubitemid 30483152)
90. Kann P, Laudes M, Piepkorn B, Heintz A, Beyer J 2001 Suppressed levels of serum cortisol after high-dose oral dexamethasone administration differ between healthy postmenopausal females and patients with established primary vertebral osteoporosis. Clin Rheumatol 20:25-29 (Pubitemid 32208443)
91. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V, Scillitani A 2007 Subclinical hypercortisolism among outpatients referred for "osteoporosis." Ann Intern Med 147:541-548
92. Molitch ME 2009 Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667-675
93. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B, Salvetti A 2003 Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213-219 (Pubitemid 36305687)
94. Erbil Y, Ademoolu E, Ozbey N, Barbaros U, Yanik BT, Salmaslioolu A, Bozbora A, Ozarmaoan S 2006 Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 30:1665-1671 (Pubitemid 44411221)
95. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder 3rd WH, Nwariaku FE 2007 "Subclinical Cushing's syndrome" is not so subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900-905; discussion 905.e1
96. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K 2008 Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. Endocr J 55:737-745
97. Sereg M, Szappanos A, Toke J, Karlinger K, Feldman K, Kaszper E, Varga I, Gláz E, Rácz K, Tóth M 2009 Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow- up study. Eur J Endocrinol 160:647-655
98. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110 (Pubitemid 32187804)
99. Reznik Y, Lefebvre H, Rohmer V, Charbonnel B, Tabarin A, Rodien P, Lecomte P, Bardet S, Coffin C, Mahoudeau J 2004 Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study. Clin Endocrinol (Oxf) 61:311-319 (Pubitemid 39287059)
100. Libé R, Coste J, Guignat L, Tissier F, Lefebvre H, Barrande G, Ajzenberg C, Tauveron I, Clauser E, Dousset B, Bertagna X, Bertherat J, Groussin L 2010 Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome. Eur J Endocrinol 163:129-138
101. de Herder WW, Hofland LJ, Usdin TB, de Jong FH, Uitterlinden P, van Koetsveld P, Mezey E, Bonner TI, Bonjer HJ, Lamberts SW 1996 Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 81:3168-3172 (Pubitemid 26296182)
102. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P 1997 Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 337:1429-1434 (Pubitemid 27497890)
103. Lacroix A, Hamet P, Boutin JM 1999 Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 341:1577-1581
104. Vidal J 2002 Updated review on the benefits of weight loss. Int J Obes Relat Metab Disord 26(Suppl 4):S25-S28 (Pubitemid 36071968)
105. Bhatnagar D, Soran H, Durrington PN 2008 Hypercholesterolaemia and its management. BMJ 337:a993
106. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
107. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B 2007 ESH-ESC practice guidelines for The management of arterial hypertension. ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25:1105-1187
108. 2010 ADA Standards of medical care in diabetes. Diabetes Care 33:S11-S61
109. Marcus R, Wong M, Heath 3rd H, Stock JL 2002 Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint. Endocr Rev 23:16-37 (Pubitemid 34185305)